On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his ...

CVS Health's shares have climbed sharply this year, largely due to much-improved results. The company is still dealing with some headwinds, but it has a plan to address them. CVS Health's diversified ...

The stock's 14-day relative strength index (RSI) is 82.46. For the uninitiated, a level above 70 is considered overbought or ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Get the latest details on Sun Pharma, including: Last ...

Shares of smallcap Sigachi Industries witnessed profit booking on Thursday after rising nearly 8 percent in early trade following the announcement of a research and development milestone in active ...

Investing.com -- Corvus Pharmaceuticals Inc (NASDAQ:CRVS) stock fell 7.1% in after-hours trading Tuesday following the company’s announcement of a $150 million public offering of common stock and ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Guardian Pharmacy Services (GRDN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Rhythm PharmaceuticalsRYTM formed a flat base after pulling back from a record high in early September. Rhythm Pharma develops treatments for rare neuroendocrine diseases and is Thursday's pick for ...

Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter. Guardian's third quarter prominently ...